Stryper frontman Michael Sweet has announced that he has been diagnosed with cancer.
In a Facebook post, the 62-year-old singer explained that a “biopsy that was performed on 11/17 (a nodule in my right thyroid) came back positive. Malignant.”
He added: “I’m scheduled for a CT and an ultrasound next Monday 12/15, and then I’ll be meeting with my doctor/surgeon on 12/22 to figure out a plan moving forward.”
Sweet shared that the specific diagnosis is “papillary thyroid cancer,” and emphasized that “the good news (is) that it’s slow growing and something that my doctor seems very optimistic about.”
He acknowledged that he has recently been “experiencing a few issues vocally and it feels a little more ‘crowded’ in there. Now I understand why.” Sweet apologized for any performances where he wasn’t at full strength but reassured fans that he is “confident that things will get better.”
While reflecting on the situation, he wrote: “Even though it’s concerning to even hear the ‘C’ word (much less be diagnosed with it), I believe that it will be behind me soon enough. I’ll get in and deal with it and heal up and be ready for 2026.”
Despite the diagnosis, Sweet confirmed that Stryper still plans to begin recording their new album on December 28. He explained: “Once we finish tracking, I’ll be undergoing another surgery to remove my right thyroid and the nodule itself.” He also thanked fans for their support and prayers, saying he’s excited to return to the stage. “I love you guys and I can’t wait to see you on the road in 2026.”
Stryper released their 16th studio album, When We Were Kings, in 2024. Their next scheduled performance is set for April 12, 2026, aboard the Monsters of Rock Cruise.
